Investor mix
6 investors on record; lead investors include Seventure Partners, 200M.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 83% |
| Accelerator & incubator | 1 | 17% |
Providers of therapeutics based on neuronal and innate lymphoid cells
6 investors on record; lead investors include Seventure Partners, 200M.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 83% |
| Accelerator & incubator | 1 | 17% |